Clinical trials recruiting for Cancer of the Breast

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
  NCT07067138 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Breast Re-irradiation After Second Ipsilateral Lumpectomy
  NCT06867484 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female · 2 locations
• COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
  NCT05972343 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
  NCT06981208 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
  NCT06749210 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 2 locations
• Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
  NCT02476786 · Phase: Phase 2 · Ages: 70 Years and older · Sex: Female · 1 location
• NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
  NCT05837455 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
  NCT01766297 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · 9 locations
• Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
  NCT07072728 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 6 locations
• Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
  NCT04968964 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Cancer of the Breast often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Cancer of the Breast trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.